Health Care & Life Sciences » Pharmaceuticals | DAE HWA Pharmaceutical Co. Ltd.

DAE HWA Pharmaceutical Co. Ltd.

DAE HWA Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW800
Market Cap
KRW554.04 B
Shares Outstanding
18.22 M
Public Float
12.46 M

Profile

Address
495 Hanu-ro
Hoengseong-gun GA 25228
Korea, Republic Of
Employees -
Website http://www.dhpharm.co.kr
Updated 09/14/2018
DAE HWA PHARM Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Pharmaceuticals Manufacturing and Distribution, Pharmaceuticals Wholesale, and Pharmaceuticals Materials Manufacturing and Distribution. Its products include cough suppressants, expectorants, and mucolytics, drugs affecting the nervous system, drugs for liver diseases, corticosteroids, and hemorrhoid disease, analgesics, anti-inflammatory, anti-pyretics, vitamins and tonics, plaster, antihistamines, skeletal muscle relaxants, cardiovascular drugs, anti-inflammatory enzymes, gastro-intestinal drugs, iron and calcium supply, topical drugs, and injections.

Financials

View All
Created with Highcharts 5.0.14DAE HWA Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.1 6761 6761021023 9113 9113 7293 72913 50813 5082013201420152016201702.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14DAE HWA Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.127 998127 998134 931134 931139 080139 080142 288142 288122 790122 79020132014201520162017025k50k75k100k125k150k

Byung-Tae Noh
Chairman & Co-Chief Executive Officer
Eun-Seok Kim
President, Co-Chief Executive Officer & Director